So far, multiple sclerosis has been divided into 5 subtypes. Researchers are increasingly moving away from this model. Instead, MS appears to be a single entity, a dynamic process. Does this mean we can now
Continue readingI don’t want to come across as a know-it-all at this point. But after my remarks on the Mollii Suit have caused excitement, I would like to briefly address the most recent court rulings on
Continue reading
Where does conventional medicine end, where do alternative healing methods begin? This article and video deal with evidence-based medicine, alternative methods and the role of the psyche in the development of MS. Prof. Mathias Mäurer
Continue reading
The Epstein-Barr virus (EBV) persists for life in the human body after a primary infection. Most often, the infection has no consequences, but the virus can also cause severe illness and is associated with the
Continue reading
There were two important highlights at the ECTRIMS Congress 2024 in Copenhagen: The Bruton tyrosine kinase inhibitor (BTKi) Tolebrutinib was able to show in Phase 3 that it significantly slows the progression of disability in
Continue reading
Prof. Mathias Mäurer discusses in this video about the new form of therapy and the current status of results on CAR-T cell therapy for MS. Please consider using the automated translation of YouTube. You can
Continue reading
In late April, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a recommendation for approval for Ocrelizumab (OCREVUS®) in a subcutaneous (s.c.) administration form. As with the
Continue reading
Radiologically isolated syndrome (RIS) refers to an incidental finding in magnetic resonance imaging (MRI) where lesions typical of multiple sclerosis (MS) are found, even though the MRI was not performed under clinical suspicion of MS,
Continue reading
Since some time ago, several oral MS drugs have been available as generics (see also MS-DocBlog Generics in MS therapy), since February 01, 2024, Tyruko® from Sandoz is also the first biosimilar approved and available
Continue reading
I would like to wish all my readers a happy, joyful and above all healthy new year 2024. At the beginning of a year, one is sometimes asked where one sees interesting potentials in terms
Continue reading
Unsere Website verwendet Cookies und sammelt dabei Informationen über Ihren Besuch, um unsere Website zu verbessern (durch Analyse), Ihnen Social Media-Inhalte und relevante Werbung anzuzeigen. Weitere Informationen finden Sie auf unserer Seite . Sie können zustimmen, indem Sie auf die Schaltfläche "Akzeptieren" klicken.
Cookie-Einstellungen
Unten können Sie auswählen, welche Art von Cookies Sie auf dieser Website zulassen. Klicken Sie auf die Schaltfläche "Cookie-Einstellungen speichern", um Ihre Auswahl zu übernehmen.
Dieser Inhalt ist gesperrt. Akzeptieren Sie Cookies in der Kategorie '%CC%', um diesen Inhalt anzuzeigen.
